9.9 C
New York
Friday, April 19, 2024
HomeMarkets
Markets

Wedbush Downgrades Pharmacyclics To Neutral

By Insider Scoop
0
9
psw-placeholder
psw-placeholder

Courtesy of Benzinga.

Related PCYC
Weekly Analyst Highlights: Oil, Tesla On Readers' Minds
In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody
Big Cap 20 Reflecting Market Leadership (Investor’s Business Daily)

Wedbush downgraded Pharmacyclics Inc. (NASDAQ: PCYC) from undefined to Neutral.

The price target for Pharmacyclics has been raised from $225.00 to $234.00.

Pharmacyclics shares have gained 61.53% over the past 52 weeks, while the S&P 500 index has surged 12.99% in the same period.

Pharmacyclics’ shares rose 2.48% to close at $221.29 yesterday.

Latest Ratings for PCYC

Date Firm Action From To
Mar 2015 Wedbush Downgrades Neutral
Feb 2015 Goldman Sachs Downgrades Buy Neutral
Feb 2015 Credit Suisse Downgrades Outperform Neutral

View More Analyst Ratings for PCYC
View the Latest Analyst Ratings

Posted-In: WedbushDowngrades Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,353FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

Load more

Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Contact us: support@philstockworld.com

© Copyright - PSW, LLC.

2024
0
Would love your thoughts, please comment.x
()
x